As we age, we don't recover from injury or illness like we did when we were young. But new research from UCSF has found gene ...
The twisting journey of Pretzel Therapeutics’ top brass appears to have come full circle, with the biotech subsuming the very ...
Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...
Junevity, a biotechnology company on a mission to extend lifespan and healthspan with cell reprogramming, today announced the publication of a peer-reviewed study in Proceedings of the National ...
News-Medical.Net on MSN
Gene regulators could restore the aging body's ability to self-repair
As we age, we don't recover from injury or illness like we did when we were young. But new research from UCSF has found gene ...
Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...
As we age, we don't recover from injury or illness like we did when we were young. But new research from UC San Francisco has ...
New Genetic Biomarker Flags Aggressive Brain Tumors. Clinicians typically classify meningiomas - the most common type of ...
Measles, which was declared to be eliminated in 2000 in the United States, has seen a resurgence, with more than 2,000 cases ...
Drinking moderate amounts of coffee daily may slow biological ageing by up to five years, according to a new study ...
Thermo Fisher Scientific Launches Invitrogen™ TaqMan™ Cells-to-CT™ HepatoExpress Kit to Simplify Liver Cell Gene Expression and Help Advance Early-Stage Drug ...
The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback